<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: How Recursion Works</title><link>http://www.bing.com:80/search?q=How+Recursion+Works</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>How Recursion Works</title><link>http://www.bing.com:80/search?q=How+Recursion+Works</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Pioneering AI Drug Discovery | Recursion</title><link>https://www.recursion.com/</link><description>Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized molecules that fuel our pipeline of potential first-in-class and best-in-class medicines.</description><pubDate>Wed, 22 Apr 2026 23:30:00 GMT</pubDate></item><item><title>Recursion Reports Fourth Quarter and Full Year 2025 Financial Results ...</title><link>https://ir.recursion.com/news-releases/news-release-details/recursion-reports-fourth-quarter-and-full-year-2025-financial</link><description>Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinical and preclinical programs advancing with defined milestones Achieved fifth program milestone with</description><pubDate>Fri, 17 Apr 2026 04:38:00 GMT</pubDate></item><item><title>Our Unique Approach to AI Drug Discovery | Recursion</title><link>https://www.recursion.com/mission</link><description>Recursion's TechBio approach: The future of AI drug discovery In traditional drug discovery, 90% of drugs fail in clinical trials, after more than a decade in development and ~$2 billion in costs. We’re changing the paradigm – leading with data, AI, and an industrialized approach to dramatically improve the cost, timeline, and probability of success of developing new medicines — because ...</description><pubDate>Wed, 22 Apr 2026 00:43:00 GMT</pubDate></item><item><title>Recursion's Drug Discovery Pipeline | Recursion</title><link>https://www.recursion.com/pipeline</link><description>Explore Recursion's dynamic drug discovery pipeline. Witness the innovations and breakthroughs in our journey. Dive deeper with us today!</description><pubDate>Thu, 23 Apr 2026 01:46:00 GMT</pubDate></item><item><title>Meet our Team | Recursion</title><link>https://www.recursion.com/team</link><description>Get acquainted with the brilliant minds behind Recursion. Dive into our team's passion, expertise, and vision. Read more about our team today!</description><pubDate>Tue, 21 Apr 2026 19:42:00 GMT</pubDate></item><item><title>Accelerating AI Drug Discovery with Open Source Datasets - recursion.com</title><link>https://www.recursion.com/news/accelerating-ai-drug-discovery-with-open-source-datasets</link><description>At Recursion, we’ve been building our own proprietary biological datasets for over a decade to help fill in those missing pieces – and we share a subset of those fit-for-purpose datasets with the broader scientific community via publicly available datasets in order to accelerate AI drug discovery research.</description><pubDate>Mon, 20 Apr 2026 02:32:00 GMT</pubDate></item><item><title>Recursion Pharmaceuticals, Inc. - Stock Quote &amp; Chart</title><link>https://ir.recursion.com/stock-information/stock-quote-chart</link><description>The Investor Relations website contains information about Recursion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.</description><pubDate>Mon, 13 Apr 2026 02:19:00 GMT</pubDate></item><item><title>Technology - Recursion OS:</title><link>https://www.recursion.com/platform</link><description>Central to our mission is the Recursion Operating System (OS), a platform powered by one of the world’s largest proprietary biological and chemical datasets. Instead of looking narrowly at a handful of diseases with existing therapeutic hypotheses, we build Maps of Biology and Chemistry that broaden our search and allow us to explore unknown areas of disease biology.</description><pubDate>Thu, 23 Apr 2026 07:15:00 GMT</pubDate></item><item><title>Clinical Trials in Rare Disease like Familial Adenomatous Polyposis and ...</title><link>https://www.recursion.com/clinical-trials</link><description>Rare disease and oncology clinical trials At Recursion, we are redefining the drug discovery and development process to bring life-changing treatments to patients faster. Recursion clinical trials are designed to address significant unmet medical needs, focusing on conditions where new options are needed most, evaluating the differentiated potential medicines developed using insights from the ...</description><pubDate>Thu, 23 Apr 2026 04:52:00 GMT</pubDate></item><item><title>Press Releases &amp; Recursion News | Recursion</title><link>https://www.recursion.com/press</link><description>Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!</description><pubDate>Tue, 21 Apr 2026 22:55:00 GMT</pubDate></item></channel></rss>